The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses

Proceedings of the National Academy of Sciences of the United States of America

Volumn 94, Issue 26, 1997, Pages 14859-14864

  Blank, Thomas ^a   Nijholt, Ingrid ^a   Teichert, Ulrich ^a   Kügler, Heidemarie ^a   Behrsing, Holger ^a,c   Fienberg, Allen ^b   Greengard, Paul ^b   Spiess, Joachim ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Calyculin A; Protein kinase; Protein phosphatase; Rat hippocampus; Rat striatum

Indexed keywords

CALYCULIN A; CYCLIC AMP; N METHYL DEXTRO ASPARTIC ACID; PHOSPHOPROTEIN; PHOSPHOPROTEIN DARPP 32; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; ENZYME ACTIVATION; GENE EXPRESSION; HIPPOCAMPUS; HUNTINGTON CHOREA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; VOLTAGE CLAMP; XENOPUS;

ANIMALS; CORPUS STRIATUM; CYCLIC AMP; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; DRUG INTERACTIONS; ENZYME INHIBITORS; HIPPOCAMPUS; N-METHYLASPARTATE; NERVE TISSUE PROTEINS; PHOSPHOPROTEINS; RATS; SIGNAL TRANSDUCTION;

EID: 0031449996     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.94.26.14859     Document Type: Article

References (53)

1. Voorn, P., Jorritsma-Byham, B., Van Dijk, B. & Buijs, R. M. (1986) J. Comp. Neurol. 251, 84-99.
2. Doucet, G., Descarries, L. & Garcia, S. (1986) Neuroscience 19, 427-445.
3. McGeer, P. L., McGeer, E. G., Scheren, U. & Singh, K. (1977) Brain Res. 128, 369-373.
4. Fonnum, F., Storm-Mathisen, J. & Divac, I. (1981) Neuroscience 6, 863-873.
5. Dube, L., Smith, A. D. & Bolam, J. P. (1988) J. Comp. Neurol. 267, 455-471.
6. Choi, D. W. (1988) Neuron 1, 623-634.
7. DiFiglia, M. (1990) Trends Neurosci. 13, 286-289.
8. Greenamyre, J. T. & O'Brien, C. F. (1991) Arch. Neurol. 48, 977-981.
9. Hollmann, M. & Heinemann, S. (1994) Annu. Rev. Neurosci. 17, 31-108.
10. Tingley, W. G., Roche, K. W., Thompson, A. K. & Huganir, R. L. (1993) Nature (London) 364, 70-73.
11. Moon, I. S., Apperson, M. L. & Kennedy, M. B. (1994) Proc. Natl. Acad. Sci. USA 91, 3954-3958.
12. Lau, L. F. & Huganir, R. L. (1995) J. Biol. Chem. 270, 20036-20041.
13. Snyder, G., Fienberg, A., Dulubova, I., Nairn, A. C. & Greengard, P. (1996) Soc. Neurosci. Abstr. 22, 153.11.
14. Colwell, C. S. & Levine, M. S. (1995) J. Neurosci. 15, 1704-1713.
15. Cepeda, C., Buchwald, N. A. & Levine, M. S. (1993) Proc. Natl. Acad. Sci. USA 90, 9576-9580.
16. Colwell, C. S. & Levine, M. S. (1994) Neuroscience 61, 497-507.
17. Portera-Cailliau, C., Price, D. L. & Martin, L. J. (1996) J. Neurochem. 66, 692-700.
18. Petralia, R. S., Wang, Y. X. & Wenthold, R. J. (1994) J. Neurosci. 14, 6102-6120.
19. Cathala, G., Savouret, J. F., Mendez, B., West, B. L., Karin, M., Martial, J. A. & Baxter, J. D. (1983) DNA 2, 329-335.
20. Kushner, L., Lerma, J., Zukin, R. S. & Bennett, M. V. L. (1988) Proc. Natl. Acad. Sci. USA 85, 3250-3254.
21. Church, G. M. & Gilbert, W. (1984) Proc. Natl. Acad. Sci. USA 81, 1991-1995.
22. Stühmer, W. (1992) Methods Enzymol. 207, 319-339.
23. Leonard, J. P. & Kelso, S. R. (1990) Neuron 2, 53-60.
24. Kelso, S. R., Nelson, T. E. & Leonard, J. P. (1992) J. Physiol. (London) 449, 705-718.
25. Stea, A., Soong, T. W. & Snutch, T. P. (1995) Neuron 15, 929-940.
26. Seamon, K. B. & Daly, J. W. (1986) Adv. Cyclic Nucleotide Protein Phosphorylation Res. 20, 1-150.
27. Laurenza, A., Sutkowski, E. M. & Seamon, K. B. (1989) Trends Pharmacol. Sci. 10, 442-447.
28. Barish, M. E. (1983) J. Physiol. (London) 342, 309-325.
29. MacDermott, A. B., Mayer, M. L., Westbrook, G. L., Smith, S. J. & Barker, J. L. (1986) Nature (London) 321, 261-263.
30. Miledi, R. & Parker, I. (1984) J. Physiol. (London) 357, 173-183.
31. Miledi, R. (1982) Proc. R. Soc. London Ser. B 215, 491-497.
32. Ishihara, H. & Martin, B. L. (1989) Biochem. Biophys. Res. Commun. 159, 871-877.
33. Suganuma, M., Fujiki, H., Furuya-Suguri, H., Yoshizawa, S., Yasumoto, S., Kato, Y., Fusetani, N. & Sugimura, T. (1990) Cancer Res. 50, 3521-3525.
34. Walaas, S. I. & Greengard, P. (1984) J. Neurosci. 4, 84-98.
35. Hemmings, H. C. Jr. & Greengard, P. (1986) J. Neurosci. 6, 1469-1481.
36. Hemmings, H. C., Jr., Greengard, P., Tung, H. Y. L. & Cohen, P. (1984) Nature (London) 310, 503-505.
37. Hemmings, H. C., Jr., Girault, J. A., Nairn, A. C., Bertuzzi, G. & Greengard, P. (1992) J. Neurochem. 59, 1053-1061.
38. Aniksztejn, L., Otani, S. & Ben-Ari, Y. (1992) Eur. J. Neurosci. 4, 500-505.
39. O'Connor, J. J., Rowan, M. J. & Anwyl, R. (1995) J. Neurosci. 15, 2013-2020.
40. Harvey, J. & Collingridge, G. H. (1993) Br. J. Pharmacol. 109, 1085-1090.
41. Greengard, P., Jen, J., Nairn, A. C. & Stevens, C. F. (1991) Science 253, 1135-1138.
42. Wang, L. Y., Salter, M. W. & MacDonald, J. F. (1991) Science 253, 1132-1135.
43. Walaas, S. I., Aswad, D. W. & Greengard, P. (1983) Nature (London) 301, 69-71.
44. Azzaro, A. J., Liccione, J. & Lecci, J. (1987) Naunyn-Schmiedebergs Arch. Pharmacol. 336, 133-138.
45. Szmigielski, A. & Zalewska-Kaszubska, L. (1991) Neuropharmacol. 30, 259-266.
46. Hemmings, H. C., Jr., Nairn, A. C. & Greengard, P. (1984) J. Biol. Chem. 259, 14491-14497.
47. Hemmings, H. C., Jr., Nairn, A. C., Elliott, J. I. & Greengard, P. (1990) J. Biol. Chem. 265, 20369-20376.
48. Weiss, S., Sebben, M., Garcia-Sainz, J. A. & Bockaert, J. (1985) Molec. Pharmacol. 27, 595-599.
49. Cooper, D. M. F., Bier-Laning, C. M., Halford, M. K., Ahlijanian, M. K. & Zahniser, N. R. (1986) Mol. Pharmacol. 29, 113-119.
50. Nishi, A., Snyder, G. L. & Greengard, P. (1997) J. Neurosci. 17, 8147-8155.
51. Ouimet, C. C., Miller, P. E., Hemmings, H. C., Jr., Walaas, S. I. & Greengard, P. (1984) J. Neurosci. 4, 111-124.
52. Halpain, S., Girault, J. A. & Greengard, P. (1990) Nature (London) 343, 369-372.
53. Colwell, C. S., Altemus, K. L., Cepeda, C. & Levine, M. S. (1996) Proc. Natl. Acad. Sci. USA 93, 1200-1204.